[ad_1] WESTON, Fla., Sept. 3, 2024 /PRNewswire/ – Apotex Corp., an affiliate of Apotex Inc. (“Apotex”), announced today that it is the first generic manufacturer to launch oxcarbazepine ER tablets, a generic version of Oxtellar XR®1, […]
[ad_1] WESTON, Fla., Sept. 3, 2024 /PRNewswire/ – Apotex Corp., an affiliate of Apotex Inc. (“Apotex”), announced today that it is the first generic manufacturer to launch oxcarbazepine ER tablets, a generic version of Oxtellar XR®1, […]